Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2013, Article ID 405295, 12 pages
http://dx.doi.org/10.1155/2013/405295
Research Article

Influence of In Vitro IL-2 or IL-15 Alone or in Combination with Hsp-70-Derived 14-mer Peptide (TKD) on the Expression of NK Cell Activatory and Inhibitory Receptors

Department of Molecular Biology and Cell Pathology, Third Faculty of Medicine, Charles University in Prague, Ruska 87, 100 00 Prague, Czech Republic

Received 20 December 2012; Accepted 14 January 2013

Academic Editor: Giamila Fantuzzi

Copyright © 2013 Ilona Hromadnikova et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. V. Z. Volloch and M. Y. Sherman, “Oncogenic potential of Hsp72,” Oncogene, vol. 18, no. 24, pp. 3648–3651, 1999. View at Publisher · View at Google Scholar · View at Scopus
  2. G. Multhoff, C. Botzler, L. Jennen, J. Schmidt, J. Ellwart, and R. Issels, “Heat shock protein 72 on tumor cells: a recognition structure for natural killer cells,” Journal of Immunology, vol. 158, no. 9, pp. 4341–4350, 1997. View at Google Scholar · View at Scopus
  3. C. Botzler, J. Ellwart, W. Günther, G. Eißner, and G. Multhoff, “Synergistic effects of heat and ET-18-OCH3 on membrane expression of hsp70 and lysis of leukemic K562 cells,” Experimental Hematology, vol. 27, no. 3, pp. 470–478, 1999. View at Publisher · View at Google Scholar · View at Scopus
  4. R. Gastpar, C. Gross, L. Rossbacher, J. Ellwart, J. Riegger, and G. Multhoff, “The cell surface-localized heat shock protein 70 epitope TKD induces migration and cytolytic activity selectively in human NK cells,” Journal of Immunology, vol. 172, no. 2, pp. 972–980, 2004. View at Google Scholar · View at Scopus
  5. S. Stangl, A. Wortmann, U. Guertler, and G. Multhoff, “Control of metastasized pancreatic carcinomas in SCID/beige mice with human IL-2/TKD-activated NK cells,” Journal of Immunology, vol. 176, no. 10, pp. 6270–6276, 2006. View at Google Scholar · View at Scopus
  6. S. W. Krause, R. Gastpar, R. Andreesen et al., “Treatment of colon and lung cancer patients with ex vivo heat shock protein 70-peptide-activated, autologous natural killer cells: a clinical phase I trial,” Clinical Cancer Research, vol. 10, no. 11, pp. 3699–3707, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. V. Milani, S. Stangl, R. Issels et al., “Anti-tumor activity of patient-derived NK cells after cell-based immunotherapy: a case report,” Journal of Translational Medicine, vol. 23, no. 7, article 50, 2009. View at Publisher · View at Google Scholar
  8. S. L. Topalian and S. A. Rosenberg, “Therapy of cancer using the adoptive transfer of activated killer cells and interleukin-2,” Acta Haematologica, vol. 78, no. 1, pp. 75–76, 1987. View at Google Scholar · View at Scopus
  9. L. L. Lanier, “Up on the tightrope: natural killer cell activation and inhibition,” Nature Immunology, vol. 9, no. 5, pp. 495–502, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Malhotra and A. Shanker, “NK cells: immune cross-talk and therapeutic implications,” Immunotherapy, vol. 3, no. 10, pp. 1143–1166, 2011. View at Publisher · View at Google Scholar
  11. S. Stangl, C. Gross, A. G. Pockley, A. A. Asea, and G. Multhoff, “Influence of Hsp70 and HLA-E on the killing of leukemic blasts by cytokine/Hsp70 peptide-activated human natural killer (NK) cells,” Cell Stress and Chaperones, vol. 13, no. 2, pp. 221–230, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Chrul, E. Polakowska, A. Szadkowska, and J. Bodalski, “Influence of interleukin IL-2 and IL-12 + IL-18 on surface expression of immunoglobulin-like receptors KIR2DL1, KIR2DL2, and KIR3DL2 in natural killer cells,” Mediators of Inflammation, vol. 2006, Article ID 46957, 6 pages, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. F. Borrego, M. Masilamani, A. I. Marusina, X. Tang, and J. E. Coligan, “The CD94/NKG2 family of receptors,” Immunologic Research, vol. 35, no. 3, pp. 263–277, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. L. Azzoni, O. Zatsepina, B. Abebe, I. M. Bennett, P. Kanakaraj, and B. Perussia, “Differential transcriptional regulation of CD161 and a novel gene, 197/15a, by IL-2, IL-15, and IL-12 in NK and T cells,” Journal of Immunology, vol. 161, no. 7, pp. 3493–3500, 1998. View at Google Scholar · View at Scopus
  15. J. A. Johnston, M. Kawamura, R. A. Kirken et al., “Phosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2,” Nature, vol. 370, no. 6485, pp. 151–153, 1994. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Hou, U. Schindler, W. J. Henzel, S. C. Wong, and S. I. McKnight, “Identification and purification of human stat proteins activated in response to interleukin-2,” Immunity, vol. 2, no. 4, pp. 321–329, 1995. View at Google Scholar · View at Scopus
  17. B. A. Witthuhn, O. Silvennoinen, O. Miura et al., “Involvement of the Jak-3 Janus kinase in signalling by interleukins 2 and 4 in lymphoid and myeloid cells,” Nature, vol. 370, no. 6485, pp. 153–157, 1994. View at Publisher · View at Google Scholar · View at Scopus
  18. U. Schindler, P. Wu, M. Rothe, M. Brasseur, and S. L. McKnight, “Components of a Stat recognition code: evidence for two layers of molecular selectivity,” Immunity, vol. 2, no. 6, pp. 689–697, 1995. View at Google Scholar · View at Scopus
  19. J. V. Ravetch and B. Perussia, “Alternative membrane forms of FcγRIII(CD16) on human natural killer cells and neutrophils. Cell type-specific expression of two genes that differ in single nucleotide substitutions,” Journal of Experimental Medicine, vol. 170, no. 2, pp. 481–497, 1989. View at Google Scholar · View at Scopus
  20. N. M. van Sorge, W. L. van der Pol, and J. G. J. van de Winkel, “FcγR polymorphisms: implications for function, disease susceptibility and immunotherapy,” Tissue Antigens, vol. 61, no. 3, pp. 189–202, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Tridandapani, R. Wardrop, C. P. Baran et al., “TGF-β1 supresses myeloid Fcγ receptor function by regulating the expression and function of the common γ-subunit,” Journal of Immunology, vol. 170, no. 9, pp. 4572–4577, 2003. View at Google Scholar · View at Scopus
  22. S. Cecchetti, F. Spadaro, L. Lugini, F. Podo, and C. Ramoni, “Functional role of phosphatidylcholine-specific phospholipase C in regulating CD16 membrane expression in natural killer cells,” European Journal of Immunology, vol. 37, no. 10, pp. 2912–2922, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. C. L. Davidson, N. L. Li, and D. N. Burshtyn, “LILRB1 polymorphism and surface phenotypes of natural killer cells,” Human Immunology, vol. 71, no. 10, pp. 942–949, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. E. W. Scott, M. C. Simon, J. Anastasi, and H. Singh, “Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages,” Science, vol. 265, no. 5178, pp. 1573–1577, 1994. View at Google Scholar · View at Scopus
  25. A. J. Courey, D. A. Holtzman, S. P. Jackson, and R. Tjian, “Synergistic activation by the glutamine-rich domains of human transcription factor Sp1,” Cell, vol. 59, no. 5, pp. 827–836, 1989. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. Nishizuka, “The role of protein kinase C in cell surface signal transduction and tumour promotion,” Nature, vol. 308, no. 5961, pp. 693–698, 1984. View at Google Scholar · View at Scopus
  27. Y. Takai, A. Kishimoto, Y. Iwasa, Y. Kawahara, T. Mori, and Y. Nishizuka, “Calcium-dependent activation of a multifunctional protein kinase by membrane phospholipids,” Journal of Biological Chemistry, vol. 254, no. 10, pp. 3692–3695, 1979. View at Google Scholar · View at Scopus
  28. M. G. Kazanietz, J. J. Barchi Jr., J. G. Omichinski, and P. M. Blumberg, “Low affinity binding of phorbol esters to protein kinase C and its recombinant cysteine-rich region in the absence of phospholipids,” Journal of Biological Chemistry, vol. 270, no. 24, pp. 14679–14684, 1995. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. J. Chwae, J. M. Lee, E. J. Kim, S. T. Lee, J. W. Soh, and J. Kim, “Activation-induced upregulation of inhibitory killer Ig-like receptors is regulated by protein kinase C,” Immunology and Cell Biology, vol. 85, no. 3, pp. 220–228, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. Y. J. Chwae, J. M. Lee, H. R. Kim et al., “Amino-acid sequence motifs for PKC-mediated membrane trafficking of the inhibitory killer Ig-like receptor,” Immunology and Cell Biology, vol. 86, no. 4, pp. 372–380, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. L. Moretta and A. Moretta, “Killer immunoglobulin-like receptors,” Current Opinion in Immunology, vol. 16, no. 5, pp. 626–633, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. H. Nakajima, A. Asai, A. Okada et al., “Transcriptional regulation of ILT family receptors,” Journal of Immunology, vol. 171, no. 12, pp. 6611–6620, 2003. View at Google Scholar · View at Scopus
  33. S. Santourlidis, H. I. Trompeter, S. Weinhold et al., “Crucial role of DNA methylation in determination of clonally distributed killer cell Ig-like receptor expression patterns in NK cells,” Journal of Immunology, vol. 169, no. 8, pp. 4253–4261, 2002. View at Google Scholar · View at Scopus
  34. H.-W. Chan, Z. B. Kurago, C. A. Stewart et al., “DNA methylation maintains allele-specific KIR gene expression in human natural killer cells,” Journal of Experimental Medicine, vol. 197, no. 2, pp. 245–255, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Kikuchi-Maki, S. I. Yusa, T. L. Catina, and K. S. Campbell, “KIR2DL4 is an IL-2-regulated NK cell receptor that exhibits limited expression in humans but triggers strong IFN-γ production,” Journal of Immunology, vol. 171, no. 7, pp. 3415–3425, 2003. View at Google Scholar · View at Scopus
  36. J. P. Goodridge, C. S. Witt, F. T. Christiansen, and H. S. Warren, “KIR2DL4 (CD158d) genotype influences expression and function in NK cells,” Journal of Immunology, vol. 171, no. 4, pp. 1768–1774, 2003. View at Google Scholar · View at Scopus
  37. H. R. Kim, Y. J. Chwae, and J. Kim, “Identification of the amino acid sequence motif for conventional PKC-mediated regulation of NKp46 surface expression,” Scandinavian Journal of Immunology, vol. 71, no. 6, pp. 413–419, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. H. R. Kim, K. H. Lee, S. J. Park et al., “Anti-cancer activity and mechanistic features of a NK cell activating molecule,” Cancer Immunology, Immunotherapy, vol. 58, no. 10, pp. 1691–1700, 2009. View at Google Scholar
  39. C. Vitale, L. Chiossone, C. Cantoni et al., “The corticosteroid-induced inhibitory effect on NK cell function reflects down-regulation and/or dysfunction of triggering receptors involved in natural cytotoxicity,” European Journal of Immunology, vol. 34, no. 11, pp. 3028–3038, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. E. Mavoungou, M. K. Bouyou-Akotet, and P. G. Kremsner, “Effects of prolactin and cortisol on natural killer (NK) cell surface expression and function of human natural cytotoxicity receptors (NKp46, NKp44 and NKp30),” Clinical and Experimental Immunology, vol. 139, no. 2, pp. 287–296, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. S. Sivori, M. Vitale, L. Morelli et al., “p46, a novel natural killer cell-specific surface molecule that mediates cell activation,” Journal of Experimental Medicine, vol. 186, no. 7, pp. 1129–1136, 1997. View at Publisher · View at Google Scholar · View at Scopus
  42. D. Pende, S. Parolini, A. Pessino et al., “Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells,” Journal of Experimental Medicine, vol. 190, no. 10, pp. 1505–1516, 1999. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Renedo, I. Arce, A. Rodríguez et al., “The human natural killer gene complex is located on chromosome 12p12-p13,” Immunogenetics, vol. 46, no. 4, pp. 307–311, 1997. View at Publisher · View at Google Scholar · View at Scopus
  44. M. Renedo, I. Arce, K. Montgomery et al., “A sequence-ready physical map of the region containing human natural killer gene complex on chromosome 12p12.3-p13.2,” Genomics, vol. 65, no. 2, pp. 129–136, 2000. View at Publisher · View at Google Scholar · View at Scopus
  45. L. L. Lanier, C. Chang, and J. H. Phillips, “Human NKR-P1A: a disulfide-linked homodimer of the C-type lectin superfamily expressed by a subset of NK and T lymphocytes,” Journal of Immunology, vol. 153, no. 6, pp. 2417–2428, 1994. View at Google Scholar · View at Scopus
  46. B. Zafirova, F. M. Wensveen, M. Gulin, and B. Polić, “Regulation of immune cell function and differentiation by the NKG2D receptor,” Cellular and Molecular Life Sciences, vol. 68, no. 21, pp. 3519–3529, 2011. View at Google Scholar
  47. N. D. Huntington, C. A. J. Vosshenrich, and J. P. Di Santo, “Developmental pathways that generate natural-killer-cell diversity in mice and humans,” Nature Reviews Immunology, vol. 7, no. 9, pp. 703–714, 2007. View at Publisher · View at Google Scholar · View at Scopus
  48. W. M. Yokoyama, S. Kim, and A. R. French, “The dynamic life of natural killer cells,” Annual Review of Immunology, vol. 22, pp. 405–429, 2004. View at Google Scholar
  49. J. P. Disanto, W. Müller, D. Guy-Grand, A. Fischer, and K. Rajewsky, “Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor γ chain,” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 2, pp. 377–381, 1995. View at Publisher · View at Google Scholar · View at Scopus
  50. N. D. Huntington, H. Puthalakath, P. Gunn et al., “Interleukin 15-mediated survival of natural killer cells is determined by interactions among Bim, Noxa and Mcl-1,” Nature Immunology, vol. 8, no. 8, pp. 856–863, 2007. View at Publisher · View at Google Scholar · View at Scopus
  51. T. Horng, J. S. Bezbradica, and R. Medzhitov, “NKG2D signaling is coupled to the interleukin 15 receptor signaling pathway,” Nature Immunology, vol. 8, no. 12, pp. 1345–1352, 2007. View at Publisher · View at Google Scholar · View at Scopus
  52. K. Jiang, B. Zhong, D. L. Gilvary et al., “Syk regulation of phosphoinositide 3-kinase-dependent NK cell function,” Journal of Immunology, vol. 168, no. 7, pp. 3155–3164, 2002. View at Google Scholar · View at Scopus
  53. K. Jiang, B. Zhong, C. Ritchey et al., “Regulation of Akt-dependent cell survival by Syk and Rac,” Blood, vol. 101, no. 1, pp. 236–244, 2003. View at Publisher · View at Google Scholar · View at Scopus
  54. V. Decot, L. Voillard, V. Latger-Cannard et al., “Natural-killer cell amplification for adoptive leukemia relapse immunotherapy: comparison of three cytokines, IL-2, IL-15, or IL-7 and impact on NKG2D, KIR2DL1, and KIR2DL2 expression,” Experimental Hematology, vol. 38, no. 5, pp. 351–362, 2010. View at Publisher · View at Google Scholar · View at Scopus
  55. C. A. Crane, S. J. Han, J. J. Barry, B. J. Ahn, L. L. Lanier, and A. T. Parsa, “TGF-β downregulates the activating receptor NKG2D on NK cells and CD8+ T cells in glioma patients,” Neuro-Oncology, vol. 12, no. 1, pp. 7–13, 2010. View at Publisher · View at Google Scholar · View at Scopus
  56. A. Fernández-Sánchez, A. Baragaño Raneros, R. Carvajal Palao et al., “DNA demethylation and histone H3K9 acetylation determine the active transcription of the NKG2D gene in human CD8 (+) T and NK cells,” Epigenetics, vol. 8, no. 1, pp. 66–78, 2012. View at Google Scholar
  57. L. D. Lieto, F. Borrego, C. H. You, and J. E. Coligan, “Human CD94 gene expression: dual promoters differing in responsiveness to IL-2 or IL-15,” Journal of Immunology, vol. 171, no. 10, pp. 5277–5286, 2003. View at Google Scholar · View at Scopus
  58. A. Rodríguez, M. Carretero, J. Glienke et al., “Structure of the human CD94 C-type lectin gene,” Immunogenetics, vol. 47, no. 4, pp. 305–309, 1998. View at Publisher · View at Google Scholar · View at Scopus
  59. A. I. Marusina, D. K. Kim, L. D. Lieto, F. Borrego, and J. E. Coligan, “GATA-3 is an important transcription factor for regulating human NKG2A gene expression,” Journal of Immunology, vol. 174, no. 4, pp. 2152–2159, 2005. View at Google Scholar · View at Scopus
  60. J. Brady, Y. Hayakawa, M. J. Smyth, and S. L. Nutt, “IL-21 induces the functional maturation of murine NK cells,” Journal of Immunology, vol. 172, no. 4, pp. 2152–2159, 2004. View at Google Scholar · View at Scopus
  61. J. S. Miller and V. McCullar, “Human natural killer cells with polyclonal lectin and immunoglobulinlike receptors develop from single hematopoietic stem cells with preferential expression of NKG2A and KIR2DL2/L3/S2,” Blood, vol. 98, no. 3, pp. 705–713, 2001. View at Publisher · View at Google Scholar · View at Scopus
  62. M. C. Mingari, C. Vitale, C. Cantoni et al., “Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor,” European Journal of Immunology, vol. 27, no. 6, pp. 1374–1380, 1997. View at Publisher · View at Google Scholar · View at Scopus
  63. S. Mori, A. Jewett, M. Cavalcanti, K. Murakami-Mori, S. Nakamura, and B. Bonavida, “Differential regulation of human NK cell-associated gene expression following activation by IL-2, IFN-Xα and PMA/ionomycin,” International Journal of Oncology, vol. 12, no. 5, pp. 1165–1170, 1998. View at Google Scholar · View at Scopus
  64. A. Sáez-Borderías, N. Romo, G. Magri, M. Gumá, A. Angulo, and M. López-Botet, “IL-12-dependent inducible expression of the CD94/NKG2A inhibitory receptor regulates CD94/NKG2C+ NK cell function,” Journal of Immunology, vol. 182, no. 2, pp. 829–836, 2009. View at Google Scholar · View at Scopus
  65. B. Jabri, J. M. Selby, H. Negulescu et al., “TCR specificity dictates CD94/NKG2A expression by human CTL,” Immunity, vol. 17, no. 4, pp. 487–499, 2002. View at Publisher · View at Google Scholar · View at Scopus
  66. C. Brostjan, T. Bellón, Y. Sobanov, M. López-Botet, and E. Hofer, “Differential expression of inhibitory and activating CD94/NKG2 receptors on NK cell clones,” Journal of Immunological Methods, vol. 264, no. 1-2, pp. 109–119, 2002. View at Publisher · View at Google Scholar · View at Scopus
  67. M. Kusumi, T. Yamashita, T. Fujii, T. Nagamatsu, S. Kozuma, and Y. Taketani, “Expression patterns of lectin-like natural killer receptors, inhibitory CD94/NKG2A, and activating CD94/NKG2C on decidual CD56bright natural killer cells differ from those on peripheral CD56dim natural killer cells,” Journal of Reproductive Immunology, vol. 70, no. 1-2, pp. 33–42, 2006. View at Publisher · View at Google Scholar · View at Scopus
  68. D. Pozo, M. Valés-Gómez, N. Mavaddat, S. C. Williamson, S. E. Chisholm, and H. Reyburn, “CD161 (human NKR-P1A) signaling in NK cells involves the activation of acid sphingomyelinase,” Journal of Immunology, vol. 176, no. 4, pp. 2397–2406, 2006. View at Google Scholar · View at Scopus
  69. A. Shibuya, D. Campbell, C. Hannum et al., “DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes,” Immunity, vol. 4, no. 6, pp. 573–581, 2006. View at Google Scholar · View at Scopus
  70. J. L. Jian, C. S. Zhu, Z. W. Xu et al., “Identification and characterization of the CD226 gene promoter,” Journal of Biological Chemistry, vol. 281, no. 39, pp. 28731–28736, 2006. View at Publisher · View at Google Scholar · View at Scopus
  71. A. Ksienzyk, B. Neumann, R. Nandakumar et al., “IRF-1 expression is essential for natural killer cells to suppress metastasis,” Cancer Research, vol. 71, no. 20, pp. 6410–6418, 2011. View at Publisher · View at Google Scholar
  72. S. E. Löfgren, A. M. Delgado-Vega, C. J. Gallant et al., “A 3′-untranslated region variant is associated with impaired expression of CD226 in T and natural killer T cells and is associated with susceptibility to systemic lupus erythematosus,” Arthritis & Rheumatism, vol. 62, no. 11, pp. 3404–3414, 2010. View at Google Scholar
  73. G. Alter, J. M. Malenfant, and M. Altfeld, “CD107a as a functional marker for the identification of natural killer cell activity,” Journal of Immunological Methods, vol. 294, no. 1-2, pp. 15–22, 2004. View at Publisher · View at Google Scholar · View at Scopus
  74. E. Aktas, U. C. Kucuksezer, S. Bilgic, G. Erten, and G. Deniz, “Relationship between CD107a expression and cytotoxic activity,” Cellular Immunology, vol. 254, no. 2, pp. 149–154, 2009. View at Publisher · View at Google Scholar · View at Scopus